Laman UtamaAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
Tutup sebelumnya
$1.20
Julat hari
$1.18 - $1.22
Julat tahun
$1.07 - $20.33
Permodalan pasaran
3.38J USD
Bilangan Purata
143.84K
Nisbah P/E
-
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 26.00K | -25.71% |
Perbelanjaan pengendalian | 2.40J | -46.74% |
Pendapatan bersih | -3.28J | 11.24% |
Margin untung bersih | -12.63K | -19.48% |
Pendapatan bagi setiap syer | -1.57 | 77.21% |
EBITDA | -2.39J | 45.93% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 2.41J | -66.55% |
Jumlah aset | 5.49J | -59.57% |
Jumlah liabiliti | 11.57J | 8.38% |
Jumlah ekuiti | -6.08J | — |
Syer tertunggak | 2.86J | — |
Harga kepada buku | -0.54 | — |
Pulangan pada aset | -127.14% | — |
Pulangan pada modal | 163.57% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -3.28J | 11.24% |
Tunai daripada operasi | -5.08J | -63.31% |
Tunai daripada pelaburan | 296.00K | -11.38% |
Tunai daripada pembiayaan | 6.65J | 4,756.93% |
Perubahan bersih dalam tunai | 1.87J | 170.90% |
Aliran tunai bebas | -7.41J | -315.84% |
Perihal
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Diasaskan
1966
Ibu pejabat
Tapak web
Pekerja
22
